ADAR1 Capital Buys NXTC Again in $1.6M Purchase Streak
NextCure, Inc. (NXTC) is showing up on our radar after ADAR1 Capital Management, LLC, a 10%+ owner of the company, made another open-market purchase of the biotech’s shares. On July 31, 2026, ADAR1 bought 3,300 shares at $4.98 apiece, a purchase worth $16,420.14. Following the trade, ADAR1’s indirectly held stake in NextCure stands at 689,416 … Read more